Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Results 1 - 10 of 25
Results/page:
12 3 > 
A global alliance for Zika virus control and prevention
ID: 734548
Start date: 2016-10-01, End date: 2019-09-30
"ZIKAlliance is a multidisciplinary project with a global ""One Health"" approach, built: on a multi-centric network of clinical cohorts in the Caribbean, Central & South America; research sites in countries where the virus has been or is currently circulating (Africa, Asia...
Programme: H2020-EU.3.1.3.
Record Number: 207455
Last updated on: 2017-08-23
Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’:  A Randomized Controlled Multicentre Trial
ID: 733203
Start date: 2017-01-01, End date: 2021-12-31
Chronic aortic aneurysms are permanent and localized dilations of the aorta that remain asymptomatic for long periods of time but continue to increase in diameter before they eventually rupture. Left untreated, the patients’ prognosis is dismal, since the internal bleeding...
Programme: H2020-EU.3.1.3.
Record Number: 207446
Last updated on: 2017-07-03
Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery
ID: 732386
Start date: 2017-01-01, End date: 2019-12-31
The main focus of TreatER is conducting a randomized, placebo-controlled, first-in-human, proof-of-concept, safety and efficacy study of intracerebrally administered CDNF protein therapy in patients with Parkinson’s disease (PD), using a neurosurgically implanted Drug...
Programme: H2020-EU.3.1.3.
Record Number: 207208
Last updated on: 2017-03-29
ORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONs
ID: 733288
Start date: 2017-01-01, End date: 2021-12-31
Current orthopaedic treatments permit spontaneous bone regeneration to unite and heal 90% bone injuries. Non-union associates pain and disability, often requiring biological enhancement. Regenerative medicine research suggests to the general public that alternative treatments...
Programme: H2020-EU.3.1.3.
Record Number: 207447
Last updated on: 2017-07-24
Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
ID: 733008
Start date: 2017-01-01, End date: 2022-12-31
IMMUNOSABR is geared towards opening up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy. High precision stereotactic ablative radiotherapy (SABR) is combined with immunotherapy to form a...
Programme: H2020-EU.3.1.3.
Record Number: 207443
Last updated on: 2017-07-17
AnTBiotic – progressing TB drug candidates to clinical proof of concept
ID: 733079
Start date: 2017-01-01, End date: 2021-12-31
Tuberculosis (TB) today rivals HIV/AIDS as the leading cause of death from infectious diseases. The number of TB patients has never been higher and the growing proportion of drug-resistant TB is threatening control strategies both in the developing and developed world, Eastern...
Programme: H2020-EU.3.1.3.
Record Number: 207216
Last updated on: 2017-06-16
Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)
ID: 733057
Start date: 2017-01-01, End date: 2020-09-30
Liver disease incidence is increasing and about 170K patients die from liver failure each year in Europe. In liver failure, the accumulation of protein bound toxins and increased susceptibility to infection cause multiorgan failure and death. Liver transplantation is the only...
Programme: H2020-EU.3.1.3.
Record Number: 207215
Last updated on: 2017-08-04
A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies
ID: 733006
Start date: 2017-01-01, End date: 2020-12-31
PACE aims to transform the treatment of patients suffering from critical limb ischemia (CLI), a disease with high medical need, because of limited treatment options and poor outcome by applying a novel, off-the-shelf allogeneic placenta-derived stromal cell product (PLX-PAD)...
Programme: H2020-EU.3.1.3.
Record Number: 207212
Last updated on: 2017-08-08
REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy
ID: 732163
Start date: 2017-01-01, End date: 2020-12-31
The World Health Organisation (WHO) has included low back pain in its list of twelve priority diseases. Notably, Degenerative disc disease (DDD) presents a large, unmet medical need which results in a disabling loss of mechanical function. Today, no efficient therapy is...
Programme: H2020-EU.3.1.3.
Record Number: 207207
Last updated on: 2017-08-22
SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
ID: 731875
Start date: 2017-01-01, End date: 2021-12-31
Liver cirrhosis is a very common chronic disease and one of the leading causes of death in European. Moreover, cirrhosis has a marked impact in patients quality of life and represents a major burden for health systems. Treatment of cirrhosis is currently based on symptomatic...
Programme: H2020-EU.3.1.3.
Record Number: 207204
Last updated on: 2017-06-02
12 3 > 
List retrieved on: 2017-12-12
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top